Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes (ACI)
A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the AcuFocus Corneal Inlay (ACI)™ ACI 7000PDT in Presbyopic Subjects
Sponsor: AcuFocus, Inc.
Listed as NCT00819299, this NA trial focuses on Presbyopia and remains completed. Sponsored by AcuFocus, Inc., it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Status: Withheld → Completed
-
Feb 2017 — Mar 2018 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Dec 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AcuFocus, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albuquerque, United States , Chesterfield, United States , Chicago, United States , Fayetteville, United States , Fort Collins, United States , Indianapolis, United States , Los Angeles, United States , Madison, United States , Newport Beach, United States , Overland Park, United States and 5 more locations